AMY WERCHINSKI: Open Payments
NPI 1265466171 · CARTHAGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 21 payments from 10 companies in 2025. Trend: 2023 $1,006 · 2024 $651 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $121 |
| Lilly USA, LLC | 4 | $93 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $77 |
| ABBVIE INC. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| UCB, Inc. | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $21 |
| PFIZER INC. | 1 | $17 |
| Incyte Corporation | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: TREMFYA, TALTZ, BLU-U, SKYRIZI, DUPIXENT, Bimzelx, NEMLUVIO, RINVOQ.
Industry payments across NY — which companies pay providers there.
